NEU neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-95

  1. 6,552 Posts.
    lightbulb Created with Sketch. 1857
    "So from this we may want to keep a keen eye on ACAD announcements"

    I have been doing that for the past few weeks. I found out about the P3 result via ACAD (before the NEU ann) and expect similar again.

    Pointy end has finally arrived - irrationally nervous but so much hangs on this result - said it before, but will shout it again - GO NEUREN! (and ACAD)
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.